A specific BCP-mediated CB2 receptor activation has been demonstrated to be at the base for example of tumor suppression in glioblastoma where it has anti-proliferative effects and plays an anti-inflammatory activity through the modulation of NF-κB and PPARγ [71]. This evidence concerns the gene PPARG and neoplasm.